Artwork

Thomas Fox에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Thomas Fox 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Mary Inman on Top FCA Health Care Recoveries and Issues from 2022

31:13
 
공유
 

Manage episode 356446299 series 2494693
Thomas Fox에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Thomas Fox 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Welcome to the award-winning FCPA Compliance Report, the longest running podcast in compliance. In this episode, I am joined by with Mary Inman, partner at Constantine Cannon. We discuss the recently released US Fraud statistics and preventative measures with Inman. Inman explains that the US Department of Justice put out statistics on the False Claims Act for 2022, with healthcare dominating the recovered funds. Inman goes on to discuss how whistleblowers can still launch cases, even if the government does not join in, as well as encourage listeners to report fraud to their respective insurance department if it later results in higher premiums for their organization.

Key Topics:

· The Increase of Managed Care Plans in Medicare [00:05:16]

· The Power of Whistleblowing and the Impact of Joining Government Cases [00:09:19]

· Medicare and Medicaid Fraud in California and Florida [00:13:21]

· Impact of Insurance Fraud on Premiums [00:17:44]

· The False Claims Act and the Escobar Decision [00:26:09]

Notable Quotes

1. "And they were basically paying kickbacks to their they know who the physicians are, who are their largest prescribers of their drugs. And they were paying kickbacks to encourage them to basically discourage them from prescribing their competitors’ products and to direct it to them."

2. "What happened here is that Mallinckrodt improperly calculated their rebate by claiming that drug that they developed in 1990 was actually termed a new drug in 2013. And so that allowed them to greatly decrease the amount of the rebate that they would have owed to the Medicaid program.""

3. "It's another kind of false billing scenario. It was notable to me that we had 2 big settlements."

4. "The whistleblower had accused the Association of basically shifting costs that it shouldn't have been reimbursing onto the Florida Medicaid program.

Resources:

Mary Inman on Linkedin

Constantine Cannon

Tom Fox on LinkedIn

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

1500 에피소드

Artwork
icon공유
 
Manage episode 356446299 series 2494693
Thomas Fox에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Thomas Fox 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Welcome to the award-winning FCPA Compliance Report, the longest running podcast in compliance. In this episode, I am joined by with Mary Inman, partner at Constantine Cannon. We discuss the recently released US Fraud statistics and preventative measures with Inman. Inman explains that the US Department of Justice put out statistics on the False Claims Act for 2022, with healthcare dominating the recovered funds. Inman goes on to discuss how whistleblowers can still launch cases, even if the government does not join in, as well as encourage listeners to report fraud to their respective insurance department if it later results in higher premiums for their organization.

Key Topics:

· The Increase of Managed Care Plans in Medicare [00:05:16]

· The Power of Whistleblowing and the Impact of Joining Government Cases [00:09:19]

· Medicare and Medicaid Fraud in California and Florida [00:13:21]

· Impact of Insurance Fraud on Premiums [00:17:44]

· The False Claims Act and the Escobar Decision [00:26:09]

Notable Quotes

1. "And they were basically paying kickbacks to their they know who the physicians are, who are their largest prescribers of their drugs. And they were paying kickbacks to encourage them to basically discourage them from prescribing their competitors’ products and to direct it to them."

2. "What happened here is that Mallinckrodt improperly calculated their rebate by claiming that drug that they developed in 1990 was actually termed a new drug in 2013. And so that allowed them to greatly decrease the amount of the rebate that they would have owed to the Medicaid program.""

3. "It's another kind of false billing scenario. It was notable to me that we had 2 big settlements."

4. "The whistleblower had accused the Association of basically shifting costs that it shouldn't have been reimbursing onto the Florida Medicaid program.

Resources:

Mary Inman on Linkedin

Constantine Cannon

Tom Fox on LinkedIn

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

1500 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드